Full Text View
Tabular View
No Study Results Posted
Related Studies
Prolonged Exposure (PE) Treatment for Post Traumatic Stress Disorder (PTSD) 20 Minutes Versus 40 Minutes
This study is currently recruiting participants.
Verified by Sheba Medical Center, February 2008
First Received: September 28, 2005   Last Updated: February 14, 2008   History of Changes
Sponsored by: Sheba Medical Center
Information provided by: Sheba Medical Center
ClinicalTrials.gov Identifier: NCT00229307
  Purpose

Comparing the efficacy of 40 minutes PE treatment to 20 minutes of the same treatment


Condition Intervention
PTSD
Behavioral: Prolonged Exposure (PE) therapy

MedlinePlus related topics: Post-Traumatic Stress Disorder
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study

Further study details as provided by Sheba Medical Center:

Primary Outcome Measures:
  • PSS-i [ Time Frame: 15 weeks and 1-year follow-up ] [ Designated as safety issue: No ]

Estimated Enrollment: 20
Study Start Date: December 2005
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Active Comparator Behavioral: Prolonged Exposure (PE) therapy
20 minutes exposure
2: Active Comparator Behavioral: Prolonged Exposure (PE) therapy
40 minutes exposure

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • PTSD

Exclusion Criteria:

  • Psychotic symptoms
  • Dissociation
  • Drug or Alcohol dependence
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00229307

Contacts
Contact: Leah Fostick, MA +972-3-5357805 Leah.Fostick@sheba.health.gov.il

Locations
Israel
Chaim Sheba Medical Center Recruiting
Ramat-Gan, Israel, 52621
Contact: Leah Fostick, MA     +972-3-5357805     Leah.Fostick@sheba.health.gov.il    
Sponsors and Collaborators
Sheba Medical Center
Investigators
Study Chair: Nitza Nacasch, MD Tel Aviv University
Principal Investigator: Joseph Zohar, MD Tel Aviv University
  More Information

No publications provided

Responsible Party: Chaim Sheba Medical Center ( Prof. Joseph Zohar )
Study ID Numbers: SHEBA-05-3709-JZ-CTIL
Study First Received: September 28, 2005
Last Updated: February 14, 2008
ClinicalTrials.gov Identifier: NCT00229307     History of Changes
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:
Post traumatic stress disorder

Study placed in the following topic categories:
Anxiety Disorders
Mental Disorders
Stress Disorders, Post-Traumatic
Stress
Stress Disorders, Traumatic

Additional relevant MeSH terms:
Anxiety Disorders
Mental Disorders
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic

ClinicalTrials.gov processed this record on May 07, 2009